Newswise — Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment that applies chemotherapeutic drugs into the peritoneal cavity as an aerosol under pressure.
PIPAC has been found to be safe and feasible if performed as an exclusive treatment in patients affected by peritoneal carcinomatosis.
Mercy Medical Center in Baltimore's Dr. Vadim Gushchin, Institute for Cancer Care, leads the 3rd International Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Symposium, Wednesday, November 16, 2016 at The Weinberg Center at Mercy, 227 St. Paul Place, Baltimore, MD
Presented by Surgical Oncology at Mercy, a division of The Institute for Cancer Care at Mercy, the course chairs for the symposium are Dr. Gushchin and Dr. Mark Raymond.
A symposium for health care professionals focusing on an innovative treatment, PIPAC – a new emerging field of research with major therapeutic potential for cancer patients. For surgical and medical oncologists, gastroenterologists, gynecologists, surgical oncology nurses, nurse practitioners, surgical technicians, pharmacologists, perfusionists and physician assistants.
Course Brochure:https://mdmercy.com/~/media/Mercy%20Site/Files/Centers%20of%20Excellence/Cancer/Surgical%20Oncology/SurgicalOncology_CME2016.ashxRegistration Please register by November 1, 2016 You may register online at: https://giving.mdmercy.com/pipac-symposium-2016Course TuitionPhysicians: $100Mid-Levels: $75Fellows/Residents: $50Medical Students/RNs/Techs: $25Registration fee includes instruction materials, meals, and complimentary parking. If you have any questions about the conference please contact Lydia Wilson at 410-332-4951 or email at [email protected].
ABOUT DR. VADIM GUSHCHIN, M.D., FACSVadim Gushchin, M.D., serves as Director of Gastrointestinal Oncology, a division of Surgical Oncology at Mercy Medical Center in Baltimore, Maryland. Dr. Gushchin offers expertise in malignancies of the gastrointestinal tract and is a skilled cancer surgeon.
He is exceptionally accomplished in minimally invasive surgery – most notably in da Vinci Robotic Surgery – as well as in traditional open surgery techniques.Gastrointestinal Cancer (GI Cancers), melanoma – more commonly known as skin cancer, and thyroid cancer are among the many cancer diagnoses Dr. Gushchin treats.
To determine the best treatment option for his surgical oncology patients, Dr. Gushchin carefully evaluates each patient’s risk factors, medical history, current clinical condition, surgical alternatives and post-surgical recovery options in order to fully develop a thorough, personalized care plan.
Dr. Gushchin comforts and compassionately walks his patients through the treatment steps needed to care for melanoma, thyroid and parathyroid disease, peritoneal surface malignancies (abdominal tumors), and recurring tumors within the colon, rectum and liver.
Dr. Gushchin is well-recognized for his experience in treating complex cancers with HIPEC (Hyperthermic Intraperitoneal Chemotherapy). Dr. Gushchin trained under the internationally renowned surgical oncologist Dr. Paul Sugarbaker to master this procedure, which involves cytoreductive surgery followed by a heated chemotherapy solution to reduce and eliminate tumors.
Dr. Gushchin has participated in over 150 HIPEC surgeries and provides patients expertise in complicated HIPEC surgeries including repeat HIPEC surgeries, simultaneous liver resections at the time of HIPEC as well as other advanced surgical treatments in conjunction with HIPEC treatment.
An international presenter and teacher, Dr. Gushchin has educated physicians around the world on HIPEC treatment and has organized teaching courses for the treatment of peritoneal surface malignancies (complex abdominal cancers that can be treated with HIPEC). As an extension of his knowledge and compassion, Dr. Gushchin has been instrumental in setting up treatment centers for peritoneal surface malignancies in other parts of the world including Lithuania, Siberia and Ukraine.
Dr. Vadim Gushchin is one of Mercy Medical Center’s top surgical oncologists. He utilizes many of the latest innovations in technology and research to provide state-of-the-art treatment options to his patients. Dr. Gushchin brings expertise in robotic surgery, using the da Vinci robot.
Patients who qualify for da Vinci robot surgery typically experience the benefits of a more precise and exacting surgery, a less invasive procedure, shorter hospital stay and faster recovery.
Dr. Vadim Gushchin is an experienced oncology surgeon and talented cancer specialist who uses the Isolated Limb Infusion technique to try to save an arm or leg that has been aggressively attacked by skin cancer.
Isolated Limb Infusion, also known as ILI, offers patients a remarkable alternative approach to metastatic melanoma on a limb. This type of skin cancer commonly leads to amputation or a disfiguring result. But Dr. Gushchin and his patients know this doesn’t always have to be the case. Isolated Limb Infusion gives Dr. Gushchin a fighting chance to save his patients’ affected arms and/or legs, reduce or shrink the cancerous tumor and avoid the need for a more radical surgery.
For more information about Dr. Gushchin and the upcoming PIPAC symposium at Mercy Medical Center in Baltimore, visit www.mdmercy.com.
RSS